Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Tenon Medical, Inc. ( (TNON) ) is now available.
Tenon Medical, Inc. held its 2025 Annual Meeting of Stockholders virtually on September 18, 2025, after previous sessions were adjourned due to a lack of quorum. During the meeting, stockholders voted on several key proposals, including the election of seven board members, the approval of warrant exercisability, amendments to the 2022 Equity Incentive Plan, and the ratification of Haskell & White LLP as the independent auditor for 2025. All proposals were approved, indicating strong shareholder support for the company’s strategic decisions.
The most recent analyst rating on (TNON) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Tenon Medical, Inc. stock, see the TNON Stock Forecast page.
Spark’s Take on TNON Stock
According to Spark, TipRanks’ AI Analyst, TNON is a Neutral.
Tenon Medical, Inc. faces significant challenges with profitability and valuation, impacting its overall score. Despite strategic growth initiatives and improved financial discipline, the company remains reliant on external funding due to negative cash flows and income. Neutral technical indicators and a strategic focus on product development provide some positive outlook, but the financial performance remains the most significant factor.
To see Spark’s full report on TNON stock, click here.
More about Tenon Medical, Inc.
Average Trading Volume: 4,503,130
Technical Sentiment Signal: Sell
Current Market Cap: $10.92M
See more data about TNON stock on TipRanks’ Stock Analysis page.